Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
St. Jude Children's Research Hospital
Research
'Special' CAR-T target works in solid tumors, but limits remain
CAR-Ts targeting a common solid tumor antigen, GRP78, work well in some cases, but an unusual resistance pattern must be overcome for wider efficacy.
Helen Floersh
Nov 28, 2023 9:00am
CARs fine-tuned with an anchor protein work against solid tumors
Feb 6, 2023 1:05pm
Novavax CEO to retire after 12 years—Chutes & Ladders
Jan 13, 2023 9:30am
AZ, FibroGen's roxadustat holds promise for sickle cell disease
Oct 18, 2022 7:05am
Manipulating T-cell fate to improve CAR-T in solid tumors
Jun 24, 2022 9:20am
Helper immune cells help Pfizer's mRNA COVID-19 vax: study
Jan 4, 2022 9:00am
